CA2361743A1 - Genes associes a des maladies du colon - Google Patents

Genes associes a des maladies du colon Download PDF

Info

Publication number
CA2361743A1
CA2361743A1 CA002361743A CA2361743A CA2361743A1 CA 2361743 A1 CA2361743 A1 CA 2361743A1 CA 002361743 A CA002361743 A CA 002361743A CA 2361743 A CA2361743 A CA 2361743A CA 2361743 A1 CA2361743 A1 CA 2361743A1
Authority
CA
Canada
Prior art keywords
gene
colon cancer
disease
polynucleotide
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002361743A
Other languages
English (en)
Inventor
Michael G. Walker
Wayne Volkmuth
Tod M. Klingler
Preeti Lal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2361743A1 publication Critical patent/CA2361743A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de gènes du cancer du côlon ainsi que des polypeptides encodés par ces gènes. L'invention concerne également des vecteurs d'expression, des cellules hôtes et des anticorps. L'invention concerne enfin des procédés pour le diagnostic, le traitement ou la prévention de maladies du côlon.
CA002361743A 1999-02-22 2000-02-01 Genes associes a des maladies du colon Abandoned CA2361743A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25538199A 1999-02-22 1999-02-22
US09/255,381 1999-02-22
PCT/US2000/002595 WO2000050588A2 (fr) 1999-02-22 2000-02-01 Genes associes a des maladies du colon

Publications (1)

Publication Number Publication Date
CA2361743A1 true CA2361743A1 (fr) 2000-08-31

Family

ID=22968072

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002361743A Abandoned CA2361743A1 (fr) 1999-02-22 2000-02-01 Genes associes a des maladies du colon

Country Status (5)

Country Link
EP (1) EP1155126A2 (fr)
JP (1) JP2002536995A (fr)
AU (1) AU3479700A (fr)
CA (1) CA2361743A1 (fr)
WO (1) WO2000050588A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048370A2 (fr) * 2000-10-31 2002-06-20 Diadexus, Inc. Compositions et methodes associees a des genes et a des proteines specifiques du colon
US20020192666A1 (en) * 2000-10-31 2002-12-19 Yongming Sun Compositions and methods relating to colon specific genes and proteins
DE10061110B4 (de) * 2000-12-07 2006-12-21 Schaller, Gerhard, Prof. Dr. med. Expression der Keratingene 8 und 18 zur Therapie von Tumoren, insbesondere des Mammakarzinoms
SI1513934T1 (sl) * 2002-06-06 2011-06-30 Oncotherapy Science Inc Geni in polipeptidi, povezani s humanimi raki kolona
CA2488404C (fr) * 2002-06-06 2012-11-27 Oncotherapy Science, Inc. Genes et polypeptides en rapport avec les cancers du colon chez l'homme
EP1380644A1 (fr) * 2002-07-08 2004-01-14 Kylix B.V. Utilisation de gènes cible spécifiques de TCF pour identifier des medicaments pour le traitement du cancer, en particulier le cancer colorectal, dans lequel TCF/beta-catenin/WNT signalisation joue un rôle central
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919064B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2919061B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919062B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
WO2009019368A2 (fr) * 2007-07-19 2009-02-12 bioMérieux Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
WO2010094499A1 (fr) 2009-02-20 2010-08-26 Ganymed Pharmaceuticals Ag Methodes et compositions de diagnostic et de traitement du cancer
EP2221063A1 (fr) 2009-02-20 2010-08-25 Ganymed Pharmaceuticals AG Procédé et compositions pour le diagnostic et le traitement du cancer
CN102741289B (zh) 2009-11-11 2016-08-03 加尼梅德药物公司 密蛋白6(cldn6)特异性的抗体
EP2404936A1 (fr) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Thérapie du cancer utilisant des anticorps in vivo dirigés sur la cible CLDN6
PL3026064T3 (pl) 2011-05-13 2019-05-31 Ganymed Pharmaceuticals Gmbh Przeciwciała do leczenia nowotworu z ekspresją klaudyny 6
WO2015014376A1 (fr) 2013-07-31 2015-02-05 Biontech Ag Diagnostic et thérapie du cancer impliquant des cellules souches cancéreuses

Also Published As

Publication number Publication date
WO2000050588A2 (fr) 2000-08-31
EP1155126A2 (fr) 2001-11-21
AU3479700A (en) 2000-09-14
WO2000050588A3 (fr) 2000-12-14
JP2002536995A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
US6277574B1 (en) Genes associated with diseases of the kidney
CA2361743A1 (fr) Genes associes a des maladies du colon
US20020102569A1 (en) Diagnostic marker for cancers
US6602667B1 (en) Inflammation-associated polynucleotides
US20030082533A1 (en) Intelectin
WO1999067384A2 (fr) Genes associes au cancer de la prostate
US6262247B1 (en) Polycyclic aromatic hydrocarbon induced molecules
JP2001526914A (ja) ヒト・調節タンパク質
WO2000021986A2 (fr) Genes de remodelage de matrice
US6534275B1 (en) Cellubrevin homologs
US20030158085A1 (en) Aquaporin-8 variant
US20100297136A1 (en) Gastric and Prostate Cancer Associated Antigens
JP2004521611A (ja) 細胞周期で発現した遺伝子
JP2001513640A (ja) 新規なヒト膜貫通４スーパーファミリータンパク質
JP2004516813A (ja) 関連腫瘍マーカー
EP1179063A2 (fr) Molecules exprimees dans l'hippocampe
JP2001521385A (ja) ヒト腫瘍関連膜タンパク質
JP2002537811A (ja) 白血球及び血液関連タンパク質
US20040023219A1 (en) Novel prostate cancer genes
JP2002525059A (ja) Ａｔｐ合成酵素サブユニットホモログ
JP2002534961A (ja) リンパ球膜タンパク質
JP2003521869A (ja) ヒト骨髄由来血清タンパク質

Legal Events

Date Code Title Description
FZDE Dead